Literature DB >> 23827688

Neurologic involvement in scleroderma: a systematic review.

Tiago Nardi Amaral1, Fernando Augusto Peres, Aline Tamires Lapa, João Francisco Marques-Neto, Simone Appenzeller.   

Abstract

OBJECTIVES: To perform a systematic review of neurologic involvement in Systemic sclerosis (SSc) and Localized Scleroderma (LS), describing clinical features, neuroimaging, and treatment.
METHODS: We performed a literature search in PubMed using the following MeSH terms, scleroderma, systemic sclerosis, localized scleroderma, localized scleroderma "en coup de sabre", Parry-Romberg syndrome, cognitive impairment, memory, seizures, epilepsy, headache, depression, anxiety, mood disorders, Center for Epidemiologic Studies Depression (CES-D), SF-36, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Patient Health Questionnaire-9 (PHQ-9), neuropsychiatric, psychosis, neurologic involvement, neuropathy, peripheral nerves, cranial nerves, carpal tunnel syndrome, ulnar entrapment, tarsal tunnel syndrome, mononeuropathy, polyneuropathy, radiculopathy, myelopathy, autonomic nervous system, nervous system, electroencephalography (EEG), electromyography (EMG), magnetic resonance imaging (MRI), and magnetic resonance angiography (MRA). Patients with other connective tissue disease knowingly responsible for nervous system involvement were excluded from the analyses.
RESULTS: A total of 182 case reports/studies addressing SSc and 50 referring to LS were identified. SSc patients totalized 9506, while data on 224 LS patients were available. In LS, seizures (41.58%) and headache (18.81%) predominated. Nonetheless, descriptions of varied cranial nerve involvement and hemiparesis were made. Central nervous system involvement in SSc was characterized by headache (23.73%), seizures (13.56%) and cognitive impairment (8.47%). Depression and anxiety were frequently observed (73.15% and 23.95%, respectively). Myopathy (51.8%), trigeminal neuropathy (16.52%), peripheral sensorimotor polyneuropathy (14.25%), and carpal tunnel syndrome (6.56%) were the most frequent peripheral nervous system involvement in SSc. Autonomic neuropathy involving cardiovascular and gastrointestinal systems was regularly described. Treatment of nervous system involvement, on the other hand, varied in a case-to-case basis. However, corticosteroids and cyclophosphamide were usually prescribed in severe cases.
CONCLUSIONS: Previously considered a rare event, nervous system involvement in scleroderma has been increasingly recognized. Seizures and headache are the most reported features in LS en coup de sabre, while peripheral and autonomic nervous systems involvement predominate in SSc. Moreover, recently, reports have frequently documented white matter lesions in asymptomatic SSc patients, suggesting smaller branches and perforating arteries involvement.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23827688     DOI: 10.1016/j.semarthrit.2013.05.002

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  41 in total

1.  High-resolution ultrasound of peripheral nerves in systemic sclerosis: a pilot study of computer-aided quantitative assessment of nerve density.

Authors:  Bianca Bignotti; Massimo Ghio; Nicoletta Panico; Giulio Tagliafico; Carlo Martinoli; Alberto Tagliafico
Journal:  Skeletal Radiol       Date:  2015-08-12       Impact factor: 2.199

2.  Clinical Reasoning: A 58-year-old woman with systemic scleroderma and progressive cervical cord compression.

Authors:  Philipp Karschnia; Robert K Fulbright; Maxwell S Laurans; Anita J Huttner; Joachim M Baehring
Journal:  Neurology       Date:  2018-09-25       Impact factor: 9.910

Review 3.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 4.  The central nervous system manifestations of localized craniofacial scleroderma: a study of 10 cases and literature review.

Authors:  Ezekiel Maloney; Sarah J Menashe; Ramesh S Iyer; Sarah Ringold; Amit K Chakraborty; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2018-07-03

Review 5.  Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances.

Authors:  Elisabeth P Golden; Steven Vernino
Journal:  Clin Auton Res       Date:  2019-05-15       Impact factor: 4.435

6.  Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire.

Authors:  Brittany L Adler; James W Russell; Laura K Hummers; Zsuzsanna H McMahan
Journal:  J Rheumatol       Date:  2018-06-15       Impact factor: 4.666

Review 7.  Facial nerve palsy in giant-cell arteritis: case-based review.

Authors:  Eveline Claeys; Olivier Gheysens; Wouter Meersseman; Eric Verbeken; Daniel Blockmans; Liesbet Henckaerts
Journal:  Rheumatol Int       Date:  2020-08-13       Impact factor: 2.631

8.  Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma.

Authors:  Julie J Paik; Andrew L Mammen; Fredrick M Wigley; Ami A Shah; Laura K Hummers; Michael Polydefkis
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-08       Impact factor: 4.794

9.  Anti-GAD epileptic encephalopathy in a toddler with Parry-Romberg syndrome.

Authors:  Stefano Sotgiu; Alessandro Consolaro; Susanna Casellato; Francesc Graus; Paolo Picco
Journal:  Neurol Sci       Date:  2019-12-11       Impact factor: 3.307

Review 10.  Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review.

Authors:  Gleb Slobodin; Doron Rimar
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.